Printer Friendly

CELOX CORPORATION ANNOUNCES PUBLIC OFFERING

 CELOX CORPORATION ANNOUNCES PUBLIC OFFERING
 MINNEAPOLIS, March 9 /PRNewswire/ -- Celox Corporation announced


today the public offering of 1,300,000 shares of common stock at a price of $3.50 per share. The shares will be sold to the public by an underwriting group managed by Mathews, Holmquist & Associates, Inc., Minneapolis. The underwriter has also agreed to exercise an option to purchase 195,000 shares to cover over-allotments.
 Net proceeds from the offering will be used for working capital to support the company's sales and marketing program and the development of its business. The company will have 2,877,769 shares of common stock outstanding after the offering.
 Minneapolis-based Celox Corporation is a developing biotechnology company that researches, develops, manufactures and markets cell biology products.
 These securities are offered for sale solely pursuant to the prospectus, a copy of which may be obtained from Mathews, Holmquist & Associates, Inc. (100 North 6th Street, Suite 306C, Minneapolis, Minn. 55403). This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities law of any such state.
 -0- 3/9/92
 /CONTACT: Milo R. Polovina of Celox Corporation, 612-933-2616, or David E. Merrill of Mathews, Holmquist & Associates, 612-337-5880/ CO: Celox Corporation ST: Minnesota IN: SU: OFR


AL -- MN015 -- 6627 03/09/92 18:00 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 9, 1992
Words:248
Previous Article:SELECTIVE INSURANCE GROUP APPOINTS ENTRINGER PRESIDENT AND CHIEF OPERATING OFFICER
Next Article:DROUGHT CONDITIONS REMAIN SERIOUS STATEWIDE
Topics:


Related Articles
CELOX ANNOUNCES PUBLIC OFFERING
CELOX SIGNS WESTERN STATES DISTRIBUTION PACT
CELOX GRANTS DISTRIBUTION RIGHTS IN JAPAN
CELOX DELIVERS FIRST SHIPMENT TO JAPAN
CELOX FILES WITH FDA FOR NEW REGISTRATION STATUS TO BECOME A MEDICAL DEVICE COMPANY -- WILL ALLOW COMPANY TO ENTER NEW BIOTECH MARKETS
CELOX BEGINS DISTRIBUTION AGREEMENT IN TAIWAN
CELOX ANNOUNCES ADDITION TO BOARD OF DIRECTORS
CELOX CORPORATION ANNOUNCES THIRD QUARTER RESULTS
CELOX CORPORATION ANNOUNCES NAME CHANGE AND ADDITIONAL ACTIVITIES AT ANNUAL MEETING
Celox Laboratories, Inc. Announces Delisting Notice from Nasdaq

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters